BDBM35949 4-pyridinoxy-2-anilinopyridine-based compound, 13
SMILES: Cc1cc(Oc2ccnc(Nc3cccc(c3)N3CCOCC3)c2)c(nc1C)-c1ccccn1
InChI Key: InChIKey=VTKXXNOAGGALPW-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TGF-beta receptor type-1 (Homo sapiens (Human)) | BDBM35949 (4-pyridinoxy-2-anilinopyridine-based compound, 13) | PDB MMDB UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 6 | n/a | 62 | n/a | n/a | 7.4 | 23 |
AstraZeneca | Assay Description A fluorescence polarization assay was used to assess the ALK5 binding capacity and biochemical activity of compounds. ALK5 protein was added to each ... | J Med Chem 52: 7901-5 (2009) Article DOI: 10.1021/jm900807w BindingDB Entry DOI: 10.7270/Q2KS6PXG | |||||||||||
More data for this Ligand-Target Pair |